INSIGHTS ON DRUG DEVELOPMENT

• EMA Support For Rare Disease Therapies

  Review how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.

• Modifying The Micro-Environment To Improve Dissolution Rate

  Discover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.

• Thunderstruck By Antibody-Drug Conjugates

  Antibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.

• Non Animal Origin Squalene For High-Risk Applications

  Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.

• Streamline Your Workflow With An Innovative Fixed-Bed System

  11/4/2025

  Discover how an innovative fixed-bed system streamlines workflows and supports consistent, high-yield manufacturing across a range of applications.

• From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined

  10/14/2025

  Explore examples of smarter SAD/MAD trial designs including multi-part and hybrid protocols, regulatory foresight, recruitment considerations, and operational strategies that keep programs moving.

• 384-Well Microplate Time Resolved Fluorescence (TRF) Immunoassay

  9/18/2024

  Examine how innovative sandwich ELISAs in a 384-well format can be utilized with a sensitive reader for high-throughput screening to quantify Human IgG and IFN gamma.

• Outlining The Trends And Challenges In The Inhaled Drug Delivery Market

  10/21/2024

  Explore the latest trends and solutions in inhaled drug delivery, with a focus on overcoming dry powder formulation challenges to advance next-generation therapeutics.

• Analyzing Biological Drug Effects In 3D

  10/24/2025

  Explore how 3D tumor microtissues paired with fluorescence-based assays offer scalable, high-sensitivity drug testing to deliver stronger signals and reproducible results compared to monolayer cultures.